Why Farbe Firma is the Top Manufacturer of Levocarnitine Injection
- Maulik Sudani
- 21 hours ago
- 6 min read
Last Updated: May 24, 2026
TL;DR: Levocarnitine Injection — levocarnitine (L-carnitine), the naturally occurring amino-acid derivative that shuttles long-chain fatty acids into the mitochondria for energy production, supplied as a clear sterile aqueous solution in ampoules and vials — is the parenteral metabolic agent clinicians rely on to prevent and treat primary and secondary carnitine deficiency, including the carnitine depletion seen in end-stage renal disease patients on chronic haemodialysis. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Levocarnitine Injection at our Gujarat, India facility and supplies it to hospital tenders, dialysis and nephrology programmes, distributors and brand owners in 30+ countries.
Key Takeaways
Drug class: Amino-acid-derivative metabolic and nutritional agent — levocarnitine carries long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation, and is used to prevent and treat primary carnitine deficiency, secondary deficiency in inborn errors of metabolism, and the carnitine depletion of patients on chronic haemodialysis. A WHO Essential Medicine and a routine nephrology and metabolic-medicine item.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, humidity-controlled handling of the hygroscopic active, qualified ampoule and vial filling lines and validated terminal moist-heat sterilisation with full container-closure integrity verification.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, drug master files and CEP-style documentation for registrations across regulated and emerging markets.
End-to-end CMO services: Contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tender-ready packaging and logistics coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Levocarnitine Injection Demands a Premium Manufacturer
Levocarnitine Injection treats a quiet but consequential problem: the body's inability to convert fat into usable energy. Levocarnitine — the biologically active L-isomer of carnitine — is the carrier molecule that ferries long-chain fatty acids across the inner mitochondrial membrane, where they are oxidised to fuel the heart, skeletal muscle and other energy-hungry tissues. When carnitine runs low, whether through an inherited transport defect, an inborn error of metabolism, or the steady losses of chronic haemodialysis, patients can develop muscle weakness, cardiomyopathy, hypoglycaemia and dialysis-related complications. For these patients a dependable parenteral carnitine supply is not optional supportive care; it is the therapy that restores normal energy metabolism.
That clinical role places real demands on the manufacturer. Levocarnitine Injection is given intravenously — often directly into the venous return line during a haemodialysis session — commonly as a 200 mg/mL solution in 1 mL (200 mg) ampoules and 5 mL (1 g) single-dose vials, so every container must deliver an accurate, uniform dose. The active itself is strongly hygroscopic: it draws moisture from the air, and uncontrolled humidity during weighing and compounding undermines both potency calculations and process consistency. The finished solution must also be held at a controlled, mildly acidic pH and rendered reliably sterile and endotoxin-free, because it is so often given to immunocompromised dialysis patients. Choosing a Levocarnitine Injection manufacturer that treats hygroscopic-API handling, dose uniformity and sterility assurance as core engineering disciplines is what keeps a metabolic-medicine supply chain dependable.
What Sets a World-Class Levocarnitine Injection Manufacturer Apart
A world-class manufacturer of Levocarnitine Injection invests in three areas weaker suppliers underfund: humidity-controlled formulation, precision low-variability filling, and a stability and sterility programme built for real-world distribution. Humidity-controlled formulation begins before the batch is even compounded — the hygroscopic active is stored, dispensed and weighed under controlled relative humidity, with moisture content verified so that the assayed potency entering the batch is the potency the label promises. Validated dissolution into large water-for-injection batches, in-process assay at multiple points and controlled fill-volume checks then ensure the first and the last container of a run carry the same accurate dose.
Precision low-variability filling and sterility assurance matter because Levocarnitine Injection is so often given to fragile patients. World-class plants compound the bulk solution under nitrogen blanket, hold and verify pH within the target band, minimise warm hold times, and validate the terminal moist-heat sterilisation cycle so that microbial lethality is achieved without unacceptable degradation. Bacterial endotoxin is controlled rigorously through depyrogenated components and validated water-for-injection systems, because a febrile reaction in a dialysis patient is a serious adverse event. All of this is documented in electronic batch records that lock deviations the moment they occur, and reinforced by 100% container leak and integrity inspection from filling through final packaging.
Quality Systems Behind Every Levocarnitine Injection
Every Farbe Firma Levocarnitine Injection batch is released only after a full stack of quality checks: identity and assay by validated stability-indicating HPLC against USP, BP, IP or EP reference standards, related-substances profiling to keep degradation products within monograph limits, optical-rotation verification to confirm the active is the L-isomer, pH, particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and content-uniformity testing appropriate to a parenteral. Certificates of analysis are issued with full traceability back to API lot, excipient lot, primary-packaging lot and the qualified person responsible for release.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental and humidity monitoring, calibrated sterilisation and depyrogenation equipment, validated terminal moist-heat cycles with load mapping, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Stability is tracked under both long-term (30 °C / 65 % RH) and accelerated (40 °C / 75 % RH) ICH Q1A conditions — Zone IVb included — so we can assure customers the Levocarnitine Injection they buy today will still meet specification when it reaches the patient months later in any climate.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Levocarnitine Injection Manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables across metabolic, nephrology, nutritional-support, emergency-medicine and critical-care categories. For Levocarnitine Injection specifically, we supply the 200 mg/mL strength in 1 mL (200 mg) ampoule and 5 mL (1 g) single-dose vial presentations as standard, with custom strengths, fill volumes and pack configurations available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier ready to hand for registration in the buyer's target market.
Our CDMO services scale cleanly from hospital and dialysis-centre supply to full national tender procurement. We prepare full eCTD and ACTD modules, drug master files, ICH Q1A stability packages, translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping and logistics to the destination. When a buyer needs Levocarnitine Injection on a tight deadline — and dialysis-programme stock often is time-critical — our regulatory, manufacturing and logistics teams move as one: dossier, artwork, production slot and shipment plan delivered as a single coordinated package, with a single accountable point of contact.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor; our quality unit answers technical queries with primary data, not slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through formulation, hygroscopic-API handling, pH control, sterilisation strategy, container-closure and stability choices in real detail. For a metabolic parenteral where dose accuracy and sterility decide patient outcomes, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Levocarnitine Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Levocarnitine Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, qualified ampoule and vial filling lines, qualified water-for-injection systems and validated environmental monitoring. WHO-GMP, USP, BP, IP and EP compliance documentation is available on request.
Which strengths and pack sizes of Levocarnitine Injection do you supply?
Our standard presentation is levocarnitine 200 mg/mL as a clear sterile solution in 1 mL (200 mg) ampoules and 5 mL (1 g) single-dose vials for intravenous use, including intradialytic administration. Custom strengths, fill volumes, ampoule and vial formats and country-specific pack configurations are available under contract manufacturing agreements — share your specification and our technical team will quote within 48 hours.
Can Farbe Firma support country-specific registrations for Levocarnitine Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability packages (long-term and accelerated), and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. Our regulatory team has supported registrations across 30+ countries in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
How does Farbe Firma handle the hygroscopic levocarnitine active during manufacturing?
Levocarnitine API is strongly hygroscopic, so it is stored, dispensed and weighed under controlled relative humidity, with moisture content verified so the potency entering each batch is accurate. The bulk solution is compounded under nitrogen blanket at a controlled, mildly acidic pH, and the terminal moist-heat sterilisation cycle is validated against a defined degradation budget. Identity, assay and the L-isomer configuration are confirmed on every batch by validated stability-indicating methods.
What is the minimum order quantity for Levocarnitine Injection contract manufacturing?
MOQs vary by strength, label complexity and dossier requirements. For the standard 200 mg/mL ampoule and vial presentations we accommodate hospital-scale, dialysis-centre and full-tender-scale orders. Contact director@farbefirma.org for a specific quotation against your specification.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments